Alectinib-associated pneumoperitoneum in stage IV non-small cell lung cancer - A case report

INTRODUCTION AND IMPORTANCE: Alectinib, a highly potent, highly selective, brain-penetrant anaplastic lymphoma kinase (ALK) inhibitor is now the first line therapy for patients with metastatic ALK-positive non small cell lung cancer (NSCLC). CASE PRESENTATION: We report a rare case of pneumoperitone...

Descripción completa

Detalles Bibliográficos
Autores principales: Maina, Renee M., Rader, Caroline A., Muenyi, Clarisse S., Battini, Ramakrishna, Zalamea, Nia N., Foretia, Denis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577531/
https://www.ncbi.nlm.nih.gov/pubmed/36268341
http://dx.doi.org/10.1016/j.amsu.2022.104601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577531/
https://www.ncbi.nlm.nih.gov/pubmed/36268341
http://dx.doi.org/10.1016/j.amsu.2022.104601

Ejemplares similares